Current Oncology | 卷:28 |
Healthcare Provider Perspectives on Adherence to Adjuvant Endocrine Therapy after Breast Cancer | |
Stephen L. K. Chia1  Lynda G. Balneaves2  Leah K. Lambert3  A. Fuchsia Howard3  Carolyn C. Gotay4  | |
[1] BC Cancer, Vancouver, BC V5Z 4E6, Canada; | |
[2] College of Nursing, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3T 2N2, Canada; | |
[3] School of Nursing, University of British Columbia, Vancouver, BC V6T 2B5, Canada; | |
[4] School of Population and Public Health, University of British Columbia, Vancouver, BC V6T 1Z3, Canada; | |
关键词: adjuvant endocrine therapy; medication adherence; breast cancer; cancer survivorship; | |
DOI : 10.3390/curroncol28020139 | |
来源: DOAJ |
【 摘 要 】
Adherence to adjuvant endocrine therapy (AET) for breast cancer is suboptimal. The purpose of this study was to: (1) explore the experiences and perspectives of healthcare providers (HCPs) in providing care to breast cancer survivors prescribed AET, (2) identify how social and structural factors influence the provision of AET-related care, and (3) ascertain HCP recommendations for optimizing AET adherence and related care. Individual, in-depth interviews were conducted with 14 HCPs using an interpretive descriptive approach to inquiry and the theoretical lens of relational autonomy. Data was analyzed using thematic and constant comparative techniques. Healthcare providers focused on four main components of AET-related care: (1) the importance of having careful conversations about AET, (2) difficulties in navigating transitions in care, (3) symptom management as a big part of their role, and (4) dealing with AET discontinuation. Recommendations to improve AET adherence focused on developing sustainable and efficient models of delivering high-quality care to women on AET. Healthcare providers play a pivotal role educating women about AET and supporting their adherence to therapy. Sustainable healthcare system innovations and new models of care that address current system gaps are needed to enhance survivorship care, AET adherence, and ultimately, reduce cancer recurrence and mortality.
【 授权许可】
Unknown